Wells Fargo & Company Forecasts Strong Price Appreciation for Insulet (NASDAQ:PODD) Stock

Insulet (NASDAQ:PODD – Get Free Report) had its price objective upped by stock analysts at Wells Fargo & Company from $305.00 to $322.00 in a report issued on Friday,Benzinga reports. The firm presently has an “overweight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s target price suggests a potential upside of 13.86% […]

Leave a Reply

Your email address will not be published.

Previous post Five9 (NASDAQ:FIVN) Stock Price Expected to Rise, Piper Sandler Analyst Says
Next post Needham & Company LLC Boosts Rivian Automotive (NASDAQ:RIVN) Price Target to $17.00